Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")
Clinical trial NCT03400254 · WITHDRAWN
Trial details
- NCT number
- NCT03400254
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-26
- Primary completion
- 2019-08-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.